Lion Point Capital, LP
CIK 1643354 · Holdings on Mar 31, 2024 · First reported May 15, 2024
Top ten holdings
Q1 2024- MRNS36.63%
- ARDX14.61%
- MIST7.87%
- G5269C1014.93%
- GERN3.79%
- INSM3.65%
- FENC3.61%
- 12122L1013.03%
- SNDX2.96%
- 05337M1042.66%
Share classes counted separately83.74%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- MRNSWeight increased · +15.91 pp20.72% → 36.63%Shares -15.20K (-0.71%)
- ARDXWeight increased · +8.23 pp6.38% → 14.61%Shares -105.00K (-9.12%)
- MISTWeight increased · +5.41 pp2.46% → 7.87%Shares +650.00K (+39.39%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 26
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | MRNSMARINUS PHARMACEUTICALS INCCOM NEW View history and evidence | $19.16M | 36.63% | 2.12M shares | 20.72% → 36.63%+15.91 pp -15.20K (-0.71%) | Reduced | ↗▾ |
| 02 | ARDXARDELYX INC View history and evidence | $7.64M | 14.61% | 1.05M shares | 6.38% → 14.61%+8.23 pp -105.00K (-9.12%) | Reduced | ↗▾ |
| 03 | MISTMILESTONE PHARMACEUTICALS IN View history and evidence | $4.12M | 7.87% | 2.30M shares | 2.46% → 7.87%+5.41 pp +650.00K (+39.39%) | Added | ↗▾ |
| 04 | G5269C101KINIKSA PHARMACEUTICALS LTDCOM CL A View history and evidence | $2.58M | 4.93% | 130.69K shares | 2.05% → 4.93%+2.88 pp 0 (0.00%) | Unchanged | ↗▾ |
| 05 | GERNGERON CORP View history and evidence | $1.98M | 3.79% | 600.00K shares | Prior unavailable +600.00K | New | ↗▾ |
| 06 | INSMINSMED INCCOM PAR $.01 View history and evidence | $1.91M | 3.65% | 70.33K shares | 1.95% → 3.65%+1.70 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | FENCFENNEC PHARMACEUTICALS INC View history and evidence | $1.89M | 3.61% | 170.00K shares | 1.10% → 3.61%+2.51 pp +60.00K (+54.55%) | Added | ↗▾ |
| 08 | 12122L101BURGERFI INTERNATIONAL INC View history and evidence | $1.59M | 3.03% | 2.75M shares | 2.11% → 3.03%+0.92 pp 0 (0.00%) | Unchanged | ↗▾ |
| 09 | SNDXSYNDAX PHARMACEUTICALS INC View history and evidence | $1.55M | 2.96% | 65.00K shares | 0.67% → 2.96%+2.29 pp +30.50K (+88.41%) | Added | ↗▾ |
| 10 | 05337M104AVADEL PHARMACEUTICALS PLCSPONSORED ADR View history and evidence | $1.39M | 2.66% | 82.50K shares | 1.01% → 2.66%+1.65 pp +2.50K (+3.13%) | Added | ↗▾ |
Options overlay 4
$126.65M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
SMTCSEMTECH CORP View history and evidence | Call | 2.50M | $68.72M | 0 (0.00%) | ▾ |
IWMISHARES RUSSELL 2000 ETFRUSSELL 2000 ETF View history and evidence | Put | 247.50K | $52.05M | +82.50K (+50.00%) | ▾ |
XBISS SPDR S&P BIOTECH ETFS&P BIOTECH View history and evidence | Put | 50.00K | $4.74M | +50.00K | ▾ |
3 / 4 options · preview only
Exited positions 6
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| HARP HARPOON THERAPEUTICS INC | Non-derivative | -228,900 | -$2.60M | SEC filing ↗ | SEC filing ↗ |
| CBAY CYMABAY THERAPEUTICS INC | Non-derivative | -82,425 | -$1.95M | SEC filing ↗ | SEC filing ↗ |
| MIRM MIRUM PHARMACEUTICALS INC | Non-derivative | -13,500 | -$398.52K | SEC filing ↗ | SEC filing ↗ |
3 / 6 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1643354 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-05-15
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 178951319
}Research all 32 reported holdings.
This page includes 30 of 32 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 32 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1643354","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1643354","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.